Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating cost and expense    
Plant operations $ 2,407,000 $ 7,213,000
Research and development cost 1,325,000 1,587,000
Impairment and loss on disposal of property, plant and equipment 9,114,000 3,080,000
General and administrative expense 10,485,000 11,967,000
Total operating expense 23,331,000 23,847,000
Loss from operations (23,331,000) (23,847,000)
Other income and expense    
Interest expense (667,000) (574,000)
Interest and Other Income 913,000 376,000
Loss on extinguishment of debt (825,000) 0
Change in fair value of warrant liability 1,266,000 (507,000)
Total other income (expense), net 687,000 (705,000)
Loss before income tax expense (22,644,000) (24,552,000)
Income tax expense (2,000) (3,000)
Net loss $ (22,646,000) $ (24,555,000)
Weighted average shares outstanding, basic and diluted (in shares) 1,494,502 641,960
Basic and diluted net loss per share (in dollars per share) $ (15.15) $ (38.25)